13-08-2020
Pavel Kapysh / Shutterstock.com
Indian drugmaker Dr Reddy’s has won approval to launch just the second generic version of heart drug Vascepa (icosapent ethyl), in another blow for Amarin.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
FDA, Dr Reddy’s, Vascepa, Amarin, Hikma Pharmaceuticals, patents, generics, Nevada, Miranda Du, cardiovascular
